GPT and metabolic dysfunction-associated steatotic liver disease: The mean ± SEM serum ALT level was also significantly higher in patients with NAFLD with > 33% hepatocytes involvement (126.99 ± 28.25 U/L in comparison to the those with mild hepatosteatosis (73.14 ± 5.98 U/L) (p = 0.020).